tradingkey.logo

Helius Medical Technologies Inc

HSDT

24.130USD

+0.960+4.14%
終値 09/19, 16:00ET15分遅れの株価
328.41K時価総額
損失額直近12ヶ月PER

Helius Medical Technologies Inc

24.130

+0.960+4.14%
詳細情報 Helius Medical Technologies Inc 企業名
Helius Medical Technologies, Inc. is a neurotech company in the medical device field. It is focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms enhancing the lives of people dealing with neurologic diseases. It develops, licenses, or acquires non-implantable technologies targeted at reducing symptoms of neurological disease or trauma. Its product Portable Neuromodulation Stimulator (PoNS) is a non-implantable medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS Therapy is integral to the overall PoNS solution and is the physical therapy applied by patients during use of the PoNS neuromodulation stimulator. PoNS is used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only.
企業情報
企業コードHSDT
会社名Helius Medical Technologies Inc
上場日Jun 27, 2014
最高経営責任者「CEO」Mr. Dane C. Andreeff
従業員数21
証券種類Ordinary Share
決算期末Jun 27
本社所在地642 Newtown Yardley Road
都市NEWTOWN
証券取引所NASDAQ Capital Market Consolidated
United States of America
郵便番号18940
電話番号12159446100
ウェブサイトhttps://heliusmedical.com/
企業コードHSDT
上場日Jun 27, 2014
最高経営責任者「CEO」Mr. Dane C. Andreeff
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Chief Financial Officer, Treasurer, Secretary, Director
Chief Financial Officer, Treasurer, Secretary, Director
15.00
-6.25%
Mr. Blane Walter
Mr. Blane Walter
Independent Director
Independent Director
3.00
--
Mr. Paul Buckman
Mr. Paul Buckman
Independent Director
Independent Director
2.00
--
Dr. Antonella Favit-Van Pelt, M.D., Ph.D.
Dr. Antonella Favit-Van Pelt, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Sherrie Perkins
Ms. Sherrie Perkins
Independent Director
Independent Director
--
--
Vice Adm. (Retd.) Edward M. (Ed) Straw
Vice Adm. (Retd.) Edward M. (Ed) Straw
Independent Director
Independent Director
--
--
Mr. Dane C. Andreeff
Mr. Dane C. Andreeff
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Dr. Joseph Chee
Dr. Joseph Chee
Executive Chairman of the Board
Executive Chairman of the Board
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Chief Financial Officer, Treasurer, Secretary, Director
Chief Financial Officer, Treasurer, Secretary, Director
15.00
-6.25%
Mr. Blane Walter
Mr. Blane Walter
Independent Director
Independent Director
3.00
--
Mr. Paul Buckman
Mr. Paul Buckman
Independent Director
Independent Director
2.00
--
Dr. Antonella Favit-Van Pelt, M.D., Ph.D.
Dr. Antonella Favit-Van Pelt, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Sherrie Perkins
Ms. Sherrie Perkins
Independent Director
Independent Director
--
--
Vice Adm. (Retd.) Edward M. (Ed) Straw
Vice Adm. (Retd.) Edward M. (Ed) Straw
Independent Director
Independent Director
--
--
収益内訳
通貨: USD更新時刻: Sun, Jul 6
通貨: USD更新時刻: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
データなし
地域別USD
会社名
収益
比率
Canada
19.00K
38.78%
United States
19.00K
38.78%
Other revenue
11.00K
22.45%
事業別
地域別
データなし
株主
更新時刻: Sun, Aug 24
更新時刻: Sun, Aug 24
株主統計
種類
株主統計
株主統計
比率
Wealthspire Advisors LLC
0.56%
Desjardins Securities Inc.
0.37%
Leonite Fund I LP
0.30%
Baader Bank AG
0.09%
UBS Financial Services, Inc.
0.07%
他の
98.61%
株主統計
株主統計
比率
Wealthspire Advisors LLC
0.56%
Desjardins Securities Inc.
0.37%
Leonite Fund I LP
0.30%
Baader Bank AG
0.09%
UBS Financial Services, Inc.
0.07%
他の
98.61%
種類
株主統計
比率
Investment Advisor
0.63%
Research Firm
0.37%
Corporation
0.32%
Investment Advisor/Hedge Fund
0.09%
Family Office
0.02%
Hedge Fund
0.02%
他の
98.56%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
37
12.45K
1.83%
+11.99K
2025Q1
40
16.72K
1.11%
-2.03K
2024Q4
43
261.97K
7.03%
-14.04K
2024Q3
43
183.78K
9.58%
-95.02K
2024Q2
46
285.33K
12.75%
+168.92K
2024Q1
47
120.01K
13.52%
+4.71K
2023Q4
50
81.05K
12.51%
-44.86K
2023Q3
52
56.40K
16.69%
-20.37K
2023Q2
56
42.39K
14.78%
-10.21K
2023Q1
55
22.24K
15.26%
-34.89K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Leonite Fund I LP
3.26K
0.47%
+3.26K
--
Jun 05, 2025
L1 Capital Global Opportunities Master Fund Ltd.
4.28K
0.61%
+4.28K
--
Jun 06, 2025
Independent Financial Partners
7.00
0%
--
--
Mar 31, 2025
Tower Research Capital LLC
5.00
0%
-2.00
-28.57%
Mar 31, 2025
Maple Leaf Partners, L.P.
44.00
0.01%
-1.00
-2.22%
May 02, 2025
Intracoastal Capital, L.L.C.
16.00
0%
+16.00
--
May 14, 2024
詳細を見る
関連ETF
銘柄名
比率
データなし
配当金
過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
Aug 16, 2023
Merger
50→1
Aug 16, 2023
Merger
50→1
Aug 16, 2023
Merger
50→1
Aug 16, 2023
Merger
50→1
Dec 31, 2020
Merger
35→1
Dec 31, 2020
Merger
35→1
日付
種類
比率
Aug 16, 2023
Merger
50→1
Aug 16, 2023
Merger
50→1
Aug 16, 2023
Merger
50→1
Aug 16, 2023
Merger
50→1
Dec 31, 2020
Merger
35→1
Dec 31, 2020
Merger
35→1
Dec 31, 2020
Merger
35→1
Dec 31, 2020
Merger
35→1
KeyAI